XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 154 filers reported holding XENON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $69,969 | +902.6% | 1,955 | +1004.5% | 0.00% | – |
| Q4 2022 | $6,979 | -99.0% | 177 | -99.1% | 0.00% | -100.0% |
| Q3 2022 | $730,000 | -54.4% | 20,211 | -61.6% | 0.00% | -60.0% |
| Q2 2022 | $1,602,000 | -29.2% | 52,678 | -28.9% | 0.01% | -47.4% |
| Q1 2022 | $2,263,000 | +398.5% | 74,039 | +409.2% | 0.02% | +375.0% |
| Q4 2021 | $454,000 | +275.2% | 14,541 | +84.3% | 0.00% | +100.0% |
| Q3 2021 | $121,000 | +255.9% | 7,888 | +328.5% | 0.00% | – |
| Q2 2021 | $34,000 | -66.0% | 1,841 | -67.2% | 0.00% | -100.0% |
| Q1 2021 | $100,000 | +8.7% | 5,611 | -6.4% | 0.00% | 0.0% |
| Q4 2020 | $92,000 | +43.8% | 5,993 | +3.0% | 0.00% | 0.0% |
| Q3 2020 | $64,000 | -66.8% | 5,820 | -62.2% | 0.00% | -66.7% |
| Q2 2020 | $193,000 | +4.3% | 15,410 | -5.5% | 0.00% | -40.0% |
| Q1 2020 | $185,000 | -44.8% | 16,307 | -36.1% | 0.01% | -16.7% |
| Q4 2019 | $335,000 | +2133.3% | 25,515 | +1452.0% | 0.01% | – |
| Q3 2019 | $15,000 | -65.9% | 1,644 | -63.2% | 0.00% | -100.0% |
| Q2 2019 | $44,000 | -39.7% | 4,470 | -37.6% | 0.00% | -50.0% |
| Q1 2019 | $73,000 | +78.0% | 7,160 | +10.4% | 0.00% | 0.0% |
| Q4 2018 | $41,000 | +583.3% | 6,485 | +980.8% | 0.00% | – |
| Q2 2018 | $6,000 | -45.5% | 600 | -72.7% | 0.00% | -100.0% |
| Q1 2018 | $11,000 | – | 2,200 | +2100.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 100 | -93.1% | 0.00% | -100.0% |
| Q3 2015 | $12,000 | -67.6% | 1,440 | -54.7% | 0.00% | -50.0% |
| Q2 2015 | $37,000 | +5.7% | 3,178 | +52.1% | 0.00% | 0.0% |
| Q1 2015 | $35,000 | – | 2,089 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |